drugset / Trial / NCT06258031
PsilOCD: A Pharmacological-Challenge Feasibility Study
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to assess the impact of psilocybin on cognitive inflexibility and neural plasticity in a cohort of people with obsessive-compulsive disorder (OCD).
Timeline
- Start
- 2022-10-28
- Primary completion
- 2024-06-28
- Completion
- 2024-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 10 mg | — |